Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319461185> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W4319461185 endingPage "543" @default.
- W4319461185 startingPage "533" @default.
- W4319461185 abstract "To compare persistence and describe dose titration among bio-naïve patients with Crohn's disease (CD) initiated on ustekinumab or adalimumab.Bio-naïve adults with CD who initiated ustekinumab or adalimumab (index date) from 23 September 2016 (ustekinumab US approval for CD) to 1 August 2019 were selected from IQVIA PharMetrics Plus. Cohorts were balanced on baseline characteristics measured over 12 months pre-index using inverse probability of treatment weights. Persistence was defined as no gaps (ustekinumab: >120 days; adalimumab: >60 days) between days of supply. Dose escalation was defined as ≥2 consecutive sub-cutaneous claims 100% above the US label daily dose in the maintenance phase; de-escalation was a return to the daily dose for ≥2 consecutive claims. Outcomes were described using weighted Kaplan-Meier models; persistence outcomes were compared using Cox's proportional hazards models.At 12 months post-index, patients in the ustekinumab (n = 948) versus adalimumab (n = 4143) cohort had a significantly higher rate of persistence on index biologic (hazard ratio [HR] 1.50; 95% confidence interval [CI]: 1.29-1.74). A total of 830 (87.6%) patients in the ustekinumab cohort and 3713 (89.6%) in the adalimumab cohort began the maintenance phase; within 12 months, 11.2% and 16.9%, underwent a dose escalation, and 26.6% and 6.3%, respectively, subsequently de-escalated to the per US label daily exposure.Bio-naïve patients with CD initiated on ustekinumab were more persistent than patients initiated on adalimumab; moreover, these patients had numerically lower dose escalation and higher de-escalation rates than patients initiated on adalimumab. Findings support the use of ustekinumab as a first-line treatment for bio-naïve patients with CD." @default.
- W4319461185 created "2023-02-09" @default.
- W4319461185 creator A5012473008 @default.
- W4319461185 creator A5019269759 @default.
- W4319461185 creator A5025682958 @default.
- W4319461185 creator A5051766298 @default.
- W4319461185 creator A5061242940 @default.
- W4319461185 creator A5070548203 @default.
- W4319461185 creator A5084091780 @default.
- W4319461185 creator A5090831117 @default.
- W4319461185 date "2023-02-20" @default.
- W4319461185 modified "2023-10-17" @default.
- W4319461185 title "Treatment persistence among bio-naïve patients with Crohn’s disease initiated on ustekinumab or adalimumab" @default.
- W4319461185 cites W1570801464 @default.
- W4319461185 cites W2012440800 @default.
- W4319461185 cites W2041446227 @default.
- W4319461185 cites W2049491523 @default.
- W4319461185 cites W2080314829 @default.
- W4319461185 cites W2095942710 @default.
- W4319461185 cites W2103210722 @default.
- W4319461185 cites W2121656227 @default.
- W4319461185 cites W2339701145 @default.
- W4319461185 cites W2605949011 @default.
- W4319461185 cites W2794595980 @default.
- W4319461185 cites W2905751446 @default.
- W4319461185 cites W2921749306 @default.
- W4319461185 cites W2922307452 @default.
- W4319461185 cites W3012205696 @default.
- W4319461185 cites W3137374823 @default.
- W4319461185 cites W3165747682 @default.
- W4319461185 cites W3168298113 @default.
- W4319461185 cites W3170143046 @default.
- W4319461185 cites W3172215576 @default.
- W4319461185 cites W4281951137 @default.
- W4319461185 cites W4294613078 @default.
- W4319461185 doi "https://doi.org/10.1080/03007995.2023.2178148" @default.
- W4319461185 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36752586" @default.
- W4319461185 hasPublicationYear "2023" @default.
- W4319461185 type Work @default.
- W4319461185 citedByCount "3" @default.
- W4319461185 countsByYear W43194611852023 @default.
- W4319461185 crossrefType "journal-article" @default.
- W4319461185 hasAuthorship W4319461185A5012473008 @default.
- W4319461185 hasAuthorship W4319461185A5019269759 @default.
- W4319461185 hasAuthorship W4319461185A5025682958 @default.
- W4319461185 hasAuthorship W4319461185A5051766298 @default.
- W4319461185 hasAuthorship W4319461185A5061242940 @default.
- W4319461185 hasAuthorship W4319461185A5070548203 @default.
- W4319461185 hasAuthorship W4319461185A5084091780 @default.
- W4319461185 hasAuthorship W4319461185A5090831117 @default.
- W4319461185 hasConcept C126322002 @default.
- W4319461185 hasConcept C207103383 @default.
- W4319461185 hasConcept C2778975655 @default.
- W4319461185 hasConcept C2779134260 @default.
- W4319461185 hasConcept C2779280984 @default.
- W4319461185 hasConcept C2780132546 @default.
- W4319461185 hasConcept C44249647 @default.
- W4319461185 hasConcept C71924100 @default.
- W4319461185 hasConcept C72563966 @default.
- W4319461185 hasConcept C90924648 @default.
- W4319461185 hasConceptScore W4319461185C126322002 @default.
- W4319461185 hasConceptScore W4319461185C207103383 @default.
- W4319461185 hasConceptScore W4319461185C2778975655 @default.
- W4319461185 hasConceptScore W4319461185C2779134260 @default.
- W4319461185 hasConceptScore W4319461185C2779280984 @default.
- W4319461185 hasConceptScore W4319461185C2780132546 @default.
- W4319461185 hasConceptScore W4319461185C44249647 @default.
- W4319461185 hasConceptScore W4319461185C71924100 @default.
- W4319461185 hasConceptScore W4319461185C72563966 @default.
- W4319461185 hasConceptScore W4319461185C90924648 @default.
- W4319461185 hasFunder F4320317188 @default.
- W4319461185 hasIssue "4" @default.
- W4319461185 hasLocation W43194611851 @default.
- W4319461185 hasLocation W43194611852 @default.
- W4319461185 hasOpenAccess W4319461185 @default.
- W4319461185 hasPrimaryLocation W43194611851 @default.
- W4319461185 hasRelatedWork W2008995310 @default.
- W4319461185 hasRelatedWork W2328449109 @default.
- W4319461185 hasRelatedWork W2463180023 @default.
- W4319461185 hasRelatedWork W2766130161 @default.
- W4319461185 hasRelatedWork W2914372963 @default.
- W4319461185 hasRelatedWork W4281781548 @default.
- W4319461185 hasRelatedWork W4282983262 @default.
- W4319461185 hasRelatedWork W4283008514 @default.
- W4319461185 hasRelatedWork W4376102407 @default.
- W4319461185 hasRelatedWork W4383422124 @default.
- W4319461185 hasVolume "39" @default.
- W4319461185 isParatext "false" @default.
- W4319461185 isRetracted "false" @default.
- W4319461185 workType "article" @default.